CompletedNot Applicable

Decisionmaking for Abnormal Uterine Bleeding (AUB)

United States380 participantsStarted 2009-05

Plain-language summary

The purpose of this study is to determine if using a computer survey about preferences for treatment of abnormal uterine bleeding (AUB) is useful and if it will improve patient satisfaction with clinical care and decision making. This study is a two-part study. The first pilot tests the computerized tool to ensure it is understood by patients, then the second part is a randomized study (computerized tool versus usual care) to see if improvements are made in satisfaction and if there are reductions in decision regret.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Have received a diagnosis of dysfunctional or abnormal uterine bleeding (AUB) that is recommended for treatment * Have not yet selected or initiated treatment for current AUB diagnosis * Be at least 18 years of age. * Be possible candidates for either medical or surgical therapy * Able to provide informed consent for treatment options for oneself Exclusion Criteria: * Are currently being treated for cancer * Any cancer diagnosis within the past 2 years (other than non-melanoma skin cancer) * AUB due to serious pelvic pathology, medications, pregnancy or systemic disease that limits their range of treatment options * Are not recommended for surgical intervention * Are not recommended for medical intervention * Are under 18 years of age * Have not received a diagnosis of AUB * Are currently being treated for AUB

What they're measuring

Differences in patient-reported satisfaction between treatment groups

Timeframe: 6 weeks

Differences in decision regret between treatment groups

Timeframe: 6 weeks

Trial details

NCT IDNCT01721304

SponsorIndiana University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2012-08